Phenotypic Transitions the Processes Involved in Regulation of Growth and Proangiogenic Properties of Stem Cells, Cancer Stem Cells and Circulating Tumor Cells.
Cancer stem Cells
Circulating Tumor cell (CTC)
Epithelial-mesenchymal Transition (EMT)
Mesenchymal-epithelial Transition (MET)
Journal
Stem cell reviews and reports
ISSN: 2629-3277
Titre abrégé: Stem Cell Rev Rep
Pays: United States
ID NLM: 101752767
Informations de publication
Date de publication:
19 Feb 2024
19 Feb 2024
Historique:
accepted:
01
02
2024
medline:
19
2
2024
pubmed:
19
2
2024
entrez:
19
2
2024
Statut:
aheadofprint
Résumé
Epithelial-mesenchymal transition (EMT) is a crucial process with significance in the metastasis of malignant tumors. It is through the acquisition of plasticity that cancer cells become more mobile and gain the ability to metastasize to other tissues. The mesenchymal-epithelial transition (MET) is the return to an epithelial state, which allows for the formation of secondary tumors. Both processes, EMT and MET, are regulated by different pathways and different mediators, which affects the sophistication of the overall tumorigenesis process. Not insignificant are also cancer stem cells and their participation in the angiogenesis, which occur very intensively within tumors. Difficulties in effectively treating cancer are primarily dependent on the potential of cancer cells to rapidly expand and occupy secondarily vital organs. Due to the ability of these cells to spread, the concept of the circulating tumor cell (CTC) has emerged. Interestingly, CTCs exhibit molecular diversity and stem-like and mesenchymal features, even when derived from primary tumor tissue from a single patient. While EMT is necessary for metastasis, MET is required for CTCs to establish a secondary site. A thorough understanding of the processes that govern the balance between EMT and MET in malignancy is crucial.
Identifiants
pubmed: 38372877
doi: 10.1007/s12015-024-10691-w
pii: 10.1007/s12015-024-10691-w
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Bellon, M., & Nicot, C. (Jan. 2023). Targeting pim kinases in hematological cancers: Molecular and clinical review. Molecular Cancer, 22(1, p. 18,). https://doi.org/10.1186/s12943-023-01721-1 .
Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A., & Fares, Y. (Mar. 2020). Molecular principles of metastasis: A hallmark of cancer revisited. Signal Transduct Target Ther, 5(1), 28. https://doi.org/10.1038/s41392-020-0134-x .
Meirson, T., Gil-Henn, H., & Samson, A. O. (2019). Invasion and metastasis: The elusive hallmark of cancer. Oncogene, 39(9), 2024–2026. https://doi.org/10.1038/s41388-019-1110-1 .
doi: 10.1038/s41388-019-1110-1
pubmed: 31745295
Lusby, R., Dunne, P., & Tiwari, V. K. (2022). Tumour invasion and dissemination, Biochem. Soc. Trans, vol. 50, no. 3, pp. 1245–1257, Jun. https://doi.org/10.1042/BST20220452 .
Muralidharan, S., et al. (Feb. 2022). Quantifying the patterns of metabolic plasticity and heterogeneity along the epithelial-hybrid-mesenchymal spectrum in Cancer. Biomolecules, 12(2), 297. https://doi.org/10.3390/biom12020297 .
Jeong, J., & Kim, J. (Mar. 2022). Combination effect of Cilengitide with Erlotinib on TGF-β1-Induced epithelial-to-mesenchymal transition in Human Non-small Cell Lung Cancer cells. International Journal of Molecular Sciences, 23(7), 3423. https://doi.org/10.3390/ijms23073423 .
Pastushenko, I., et al. (2018). Identification of the tumour transition states occurring during EMT. Nature, 556(7702), 463–468. https://doi.org/10.1038/s41586-018-0040-3 .
doi: 10.1038/s41586-018-0040-3
pubmed: 29670281
Zheng, X. (2015). Nov., Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer, Nature, vol. 527, no. 7579, pp. 525–530, https://doi.org/10.1038/nature16064 .
Primeaux, M., Gowrikumar, S., & Dhawan, P. (Jun. 2022). Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis. Clinical & Experimental Metastasis, 39(3), 391–406. https://doi.org/10.1007/s10585-022-10146-x .
Alotaibi, H. (2022). Crif1 is required for proper mesenchymal to epithelial transition. Cumhur Sci J, 43(2), 165–170. https://doi.org/10.17776/csj.1062126 .
doi: 10.17776/csj.1062126
Plygawko, A. T., Kan, S., & Campbell, K. (2020). Epithelial-mesenchymal plasticity: emerging parallels between tissue morphogenesis and cancer metastasis, Philos. Trans. R. Soc. Lond. B. Biol. Sci, vol. 375, no. 1809, p. 20200087, Oct. https://doi.org/10.1098/rstb.2020.0087 .
Chen, J., Han, Q., & Pei, D. (2011). EMT and MET as paradigms for cell fate switching. Journal of Molecular Cell Biology, 4(2), 66–69. https://doi.org/10.1093/jmcb/mjr045 .
doi: 10.1093/jmcb/mjr045
pubmed: 22140271
Safa, A. R. (2022). Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces, Cancer drug Resist. (Alhambra, Calif.), vol. 5, no. 4, pp. 850–872, Aug. https://doi.org/10.20517/cdr.2022.20 .
Rodriguez-Aznar, E., Wiesmüller, L., Sainz, B. Jr., & Hermann, P. C. (Aug. 2019). EMT and stemness-key players in pancreatic Cancer stem cells. Cancers (Basel), 11(8), 1136. https://doi.org/10.3390/cancers11081136 .
Ribatti, D., Tamma, R., & Annese, T. (Jun. 2020). Epithelial-mesenchymal transition in Cancer: A historical overview. Transl Oncol, 13(6), 100773. https://doi.org/10.1016/j.tranon.2020.100773 .
Huang, Y., Hong, W., & Wei, X. (Sep. 2022). The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. Journal of Hematology & Oncology, 15(1), 129. https://doi.org/10.1186/s13045-022-01347-8 .
Chiang, S. P. H., Cabrera, R. M., & Segall, J. E. (Jul. 2016). Tumor cell intravasation. American Journal of Physiology. Cell Physiology, 311(1), C1–C14. https://doi.org/10.1152/ajpcell.00238.2015 .
Kurma, K., & Alix-Panabières, C. (May 2023). Mechanobiology and survival strategies of circulating tumor cells: A process towards the invasive and metastatic phenotype. Front cell Dev Biol, 11, 1188499. https://doi.org/10.3389/fcell.2023.1188499 .
Yin, W., Han, Y. M., Li, Z. L., Huang, Z. X., Huang, L., & Zhong, X. G. (2020). Clinical significance of perioperative EMT-CTCs in rectal cancer patients receiving open/laparoscopic surgery. Neoplasma, 67(05), 1131–1138. https://doi.org/10.4149/neo_2020_190709n611 .
doi: 10.4149/neo_2020_190709n611
pubmed: 32412772
Bian, X., Ma, K., Zhang, C., & Fu, X. (Jun. 2019). Therapeutic angiogenesis using stem cell-derived extracellular vesicles: An emerging approach for treatment of ischemic diseases. Stem Cell Research & Therapy, 10(1), 158. https://doi.org/10.1186/s13287-019-1276-z .
Azari, Z. (2022). Jul., Stem cell-mediated angiogenesis in skin tissue engineering and wound healing, Wound Repair Regen, vol. 30, no. 4, pp. 421–435, https://doi.org/10.1111/wrr.13033 .
Butti, R., Gunasekaran, V. P., Kumar, T. V. S., Banerjee, P., & Kundu, G. C. (2019). Breast cancer stem cells: Biology and therapeutic implications. Int J Biochem & Cell Biol, 107, 38–52. https://doi.org/10.1016/j.biocel.2018.12.001 .
doi: 10.1016/j.biocel.2018.12.001
Zakrzewski, W., Dobrzyński, M., Szymonowicz, M., & Rybak, Z. (Feb. 2019). Stem cells: Past, present, and future. Stem Cell Research & Therapy, 10(1), 68. https://doi.org/10.1186/s13287-019-1165-5 .
Rosner, M., Horer, S., Feichtinger, M., & Hengstschläger, M. (Jun. 2023). Multipotent fetal stem cells in reproductive biology research. Stem Cell Research & Therapy, 14(1), 157. https://doi.org/10.1186/s13287-023-03379-4 .
Musa, S., & Romano, N. (2023). Stem cell immunology. Immunology for Dentistry (pp. 48–60). Wiley. https://doi.org/10.1002/9781119893035.ch5 .
Charitos, I. A. (2021). Stem Cells: A Historical Review about Biological, Religious, and Ethical Issues, Stem Cells Int, vol. p. 9978837, Apr. 2021, https://doi.org/10.1155/2021/9978837 .
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009). Epithelial-mesenchymal transitions in Development and Disease. Cell, 139(5), 871–890. https://doi.org/10.1016/j.cell.2009.11.007 .
doi: 10.1016/j.cell.2009.11.007
pubmed: 19945376
Aban, C. E. (2048). Downregulation of E-cadherin in pluripotent stem cells triggers partial EMT, Sci. Rep, vol. 11, no. 1, p. Jan. 2021, https://doi.org/10.1038/s41598-021-81735-1 .
Lamouille, S., Xu, J., & Derynck, R. (2014). Molecular mechanisms of epithelial-mesenchymal transition, Nat. Rev. Mol. Cell Biol, vol. 15, no. 3, pp. 178–196, Mar. https://doi.org/10.1038/nrm3758 .
Gonzalez, D. M., & Medici, D. (Sep. 2014). Signaling mechanisms of the epithelial-mesenchymal transition. Science Signaling, 7(344), re8–re8. https://doi.org/10.1126/scisignal.2005189 .
Xiao, K., et al. (Oct. 2020). Mesenchymal stem cells reverse EMT process through blocking the activation of NF-κB and hedgehog pathways in LPS-induced acute lung injury. Cell Death and Disease, 11(10), 863. https://doi.org/10.1038/s41419-020-03034-3 .
Han, B., et al. (2018). Adipose-derived mesenchymal stem cells treatments for fibroblasts of fibrotic scar via downregulating TGF-β1 and Notch-1 expression enhanced by photobiomodulation therapy. Lasers in Medical Science, 34(1), 1–10. https://doi.org/10.1007/s10103-018-2567-9 .
doi: 10.1007/s10103-018-2567-9
pubmed: 30367294
Yao, Y., Chen, R., Wang, G., Zhang, Y., & Liu, F. (2019). Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium, Stem Cell Res. Ther, vol. 10, no. 1, p. 225, Jul. https://doi.org/10.1186/s13287-019-1332-8 .
Yu, Y., et al. (2020). Human umbilical cord mesenchymal stem cell attenuates renal fibrosis via TGF-β/Smad signaling pathways in vivo and in vitro. European Journal of Pharmacology, 883, 173343. https://doi.org/10.1016/j.ejphar.2020.173343 .
doi: 10.1016/j.ejphar.2020.173343
pubmed: 32629029
Meng, Y., Liu, Y., Dakou, E., Gutierrez, G. J., & Leyns, L. (2020). Polycomb group RING finger protein 5 influences several developmental signaling pathways during the in vitro differentiation of mouse embryonic stem cells. Dev Growth & Differ, 62(4), 232–242. https://doi.org/10.1111/dgd.12659 .
doi: 10.1111/dgd.12659
Qiao, B., Gopalan, V., Chen, Z., Smith, R. A., Tao, Q., & Lam, A. K. (2012). Epithelial–mesenchymal transition and mesenchymal–epithelial transition are essential for the acquisition of stem cell properties in hTERT-immortalised oral epithelial cells. Biology of the Cell, 104(8), 476–489. https://doi.org/10.1111/boc.201100077 .
doi: 10.1111/boc.201100077
pubmed: 22548277
Li, B., Zheng, Y. W., Sano, Y., & Taniguchi, H. (Feb. 2011). Evidence for mesenchymal-epithelial transition associated with mouse hepatic stem cell differentiation. PLoS One, 6(2), e17092–e17092. https://doi.org/10.1371/journal.pone.0017092 .
Bisht, S., Nigam, M., Kunjwal, S. S., Sergey, P., Mishra, A. P., & Sharifi-Rad, J. (2022). Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting, Stem Cells Int, vol. p. 9653244, Jun. 2022, https://doi.org/10.1155/2022/9653244 .
Neumüller, R. A., & Knoblich, J. A. (2009). Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancer, Genes Dev, vol. 23, no. 23, pp. 2675–2699, Dec. https://doi.org/10.1101/gad.1850809 .
Wang, R., et al. (Feb. 2016). Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells. Oncotarget, 7(5), 5754–5768. https://doi.org/10.18632/oncotarget.6805 .
Aramini, B., et al. (Feb. 2022). Dissecting Tumor Growth: The role of Cancer Stem cells in Drug Resistance and Recurrence. Cancers (Basel), 14(4), 976. https://doi.org/10.3390/cancers14040976 .
Maugeri-Saccà, M., Bartucci, M., & De Maria, R. (2012). DNA Damage Repair Pathways in Cancer Stem Cells, Mol. Cancer Ther, vol. 11, no. 8, pp. 1627–1636, https://doi.org/10.1158/1535-7163.mct-11-1040 .
Hollier, B. G. (2013). Mar., FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer, Cancer Res, vol. 73, no. 6, pp. 1981–1992, https://doi.org/10.1158/0008-5472.CAN-12-2962 .
Mani, S. A., et al. (May 2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133(4), 704–715. https://doi.org/10.1016/j.cell.2008.03.027 .
Morel, A. P., Lièvre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008). Generation of breast cancer stem cells through epithelial-mesenchymal transition, PLoS One, vol. 3, no. 8, pp. e2888–e2888, Aug. https://doi.org/10.1371/journal.pone.0002888 .
McCoy, E. L. (2009). Sep., Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition, J. Clin. Invest, vol. 119, no. 9, pp. 2663–2677, https://doi.org/10.1172/JCI37691 .
Evdokimova, V., et al. (2009). Translational activation of Snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell, 15(5), 402–415. https://doi.org/10.1016/j.ccr.2009.03.017 .
doi: 10.1016/j.ccr.2009.03.017
pubmed: 19411069
Yin, X. (2010). Oct., ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells, J. Cell Sci, vol. 123, no. Pt 20, pp. 3558–3565, https://doi.org/10.1242/jcs.064915 .
Jo, M., Eastman, B. M., Webb, D. L., Stoletov, K., Klemke, R., & Gonias, S. L. (2010). Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells, Cancer Res, vol. 70, no. 21, pp. 8948–8958, Nov. https://doi.org/10.1158/0008-5472.CAN-10-1936 .
Wellner, U., et al. (2009). The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nature Cell Biology, 11(12), 1487–1495. https://doi.org/10.1038/ncb1998 .
doi: 10.1038/ncb1998
pubmed: 19935649
Shimono, Y. (2009). Aug., Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells, Cell, vol. 138, no. 3, pp. 592–603, https://doi.org/10.1016/j.cell.2009.07.011 .
Tam, W. L., et al. (Sep. 2013). Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells. Cancer Cell, 24(3), 347–364. https://doi.org/10.1016/j.ccr.2013.08.005 .
Bowers, L. W., et al. (May 2018). Leptin Signaling mediates obesity-Associated CSC Enrichment and EMT in Preclinical TNBC models. Molecular Cancer Research, 16(5), 869–879. https://doi.org/10.1158/1541-7786.MCR-17-0508 .
Jiang, R., et al. (2012). EMT and CSC-like properties mediated by the IKKβ/IκBα/RelA signal pathway via the transcriptional regulator, Snail, are involved in the arsenite-induced neoplastic transformation of human keratinocytes. Archives of Toxicology, 87(6), 991–1000. https://doi.org/10.1007/s00204-012-0933-0 .
doi: 10.1007/s00204-012-0933-0
pubmed: 23069812
Wang, Y., et al. (2019). PM2.5 induces EMT and promotes CSC properties by activating notch pathway in vivo and vitro. Ecotoxicology and Environmental Safety, 178, 159–167. https://doi.org/10.1016/j.ecoenv.2019.03.086 .
doi: 10.1016/j.ecoenv.2019.03.086
pubmed: 31002970
Bosukonda, A., & Carlson, W. D. (2017). Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition. Biochemical Society Transactions, 45(1), 223–228. https://doi.org/10.1042/bst20160177 .
doi: 10.1042/bst20160177
pubmed: 28202676
Burk, U. (2008). Jun., A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells, EMBO Rep, vol. 9, no. 6, pp. 582–589, https://doi.org/10.1038/embor.2008.74 .
Biddle, A., et al. (2011). Cancer Stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Research, 71, 5317–5326. https://doi.org/10.1158/0008-5472.can-11-1059 .
doi: 10.1158/0008-5472.can-11-1059
pubmed: 21685475
Guo, Y., et al. (2022). PKD-1 signaling is required for the maintenance of CSCs with epithelial-mesenchymal plasticity in pancreatic neuroendocrine tumors. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2022.02.17.480869 .
doi: 10.1101/2022.02.17.480869
Farabaugh, S. M., Micalizzi, D. S., Jedlicka, P., Zhao, R., & Ford, H. L. (2012). Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties, Oncogene, vol. 31, no. 5, pp. 552–562, Feb. https://doi.org/10.1038/onc.2011.259 .
Li, J., & Zhou, B. P. (Feb. 2011). Activation of β-catenin and akt pathways by twist are critical for the maintenance of EMT associated cancer stem cell-like characters. Bmc Cancer, 11, 49. https://doi.org/10.1186/1471-2407-11-49 .
Deng, Z., Wu, S., Wang, Y., & Shi, D. (Sep. 2022). Circulating tumor cell isolation for cancer diagnosis and prognosis. EBioMedicine, 83, 104237. https://doi.org/10.1016/j.ebiom.2022.104237 .
Raeisi, M., Zehtabi, M., Velaei, K., Fayyazpour, P., Aghaei, N., & Mehdizadeh, A. (2022). Anoikis in cancer: The role of lipid signaling. Cell Biology International, 46(11), 1717–1728. https://doi.org/10.1002/cbin.11896 .
doi: 10.1002/cbin.11896
pubmed: 36030535
Gkountela, S. (2019). Jan., Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding, Cell, vol. 176, no. 1–2, pp. 98–112.e14, https://doi.org/10.1016/j.cell.2018.11.046 .
Lin, D., et al. (Nov. 2021). Circulating tumor cells: Biology and clinical significance. Signal Transduct Target Ther, 6(1), 404. https://doi.org/10.1038/s41392-021-00817-8 .
Ring, A., Nguyen-Sträuli, B. D., Wicki, A., & Aceto, N. (2023). Biology, vulnerabilities and clinical applications of circulating tumour cells, Nat. Rev. Cancer, vol. 23, no. 2, pp. 95–111, Feb. https://doi.org/10.1038/s41568-022-00536-4 .
Armstrong, A. J. (2011). Aug., Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers, Mol. Cancer Res, vol. 9, no. 8, pp. 997–1007, https://doi.org/10.1158/1541-7786.MCR-10-0490 .
Padmanaban, V. (2019). Sep., E-cadherin is required for metastasis in multiple models of breast cancer, Nature, vol. 573, no. 7774, pp. 439–444, https://doi.org/10.1038/s41586-019-1526-3 .
Tashireva, L. A. (2021). Mar., Heterogeneous Manifestations of Epithelial-Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients, Int. J. Mol. Sci, vol. 22, no. 5, p. 2504, https://doi.org/10.3390/ijms22052504 .
Xin, Y., Li, K., Yang, M., & Tan, Y. (Oct. 2020). Fluid shear stress induces EMT of circulating Tumor cells via JNK Signaling in Favor of their survival during Hematogenous Dissemination. International Journal of Molecular Sciences, 21(21), 8115. https://doi.org/10.3390/ijms21218115 .
Genna, A., et al. (Jun. 2020). EMT-Associated Heterogeneity in circulating Tumor cells: Sticky friends on the Road to Metastasis. Cancers (Basel), 12(6), 1632. https://doi.org/10.3390/cancers12061632 .
Dou, R. (2021). Dec., EMT-cancer cells-derived exosomal miR-27b-3p promotes circulating tumour cells-mediated metastasis by modulating vascular permeability in colorectal cancer, Clin. Transl. Med, vol. 11, no. 12, pp. e595–e595, https://doi.org/10.1002/ctm2.595 .
Wang, X. (2023). Mar., µ-opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial, Cancer Commun. (London, England), vol. 43, no. 3, pp. 365–386, https://doi.org/10.1002/cac2.12408 .
Orrapin, S. (2022). Jul., Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review, Cancers (Basel), vol. 14, no. 14, p. 3373, https://doi.org/10.3390/cancers14143373 .
Shibue, T., & Weinberg, R. A. (2017). EMT, CSCs, and drug resistance: The mechanistic link and clinical implications. Nature Reviews. Clinical Oncology, 14(10), 611–629. https://doi.org/10.1038/nrclinonc.2017.44 .
doi: 10.1038/nrclinonc.2017.44
pubmed: 28397828
pmcid: 5720366
De Craene, B., & Berx, G. (2013). Regulatory networks defining EMT during cancer initiation and progression. Nature Reviews Cancer, 13(2), 97–110. https://doi.org/10.1038/nrc3447 .
doi: 10.1038/nrc3447
pubmed: 23344542
Babaei, G., Aziz, S. G. G., & Jaghi, N. Z. Z. (2021). EMT, cancer stem cells and autophagy; the three main axes of metastasis. Biomed & Pharmacother, 133, 110909. https://doi.org/10.1016/j.biopha.2020.110909 .
doi: 10.1016/j.biopha.2020.110909
Kaufhold, S., & Bonavida, B. (Aug. 2014). Central role of Snail1 in the regulation of EMT and resistance in cancer: A target for therapeutic intervention. Journal of Experimental & Clinical Cancer Research : Cr, 33(1), 62. https://doi.org/10.1186/s13046-014-0062-0 .
Jones, C. A., & Hazlehurst, L. A. (Sep. 2021). Role of Calcium Homeostasis in modulating EMT in Cancer. Biomedicines, 9(9), 1200. https://doi.org/10.3390/biomedicines9091200 .
Battista, T., Fiorillo, A., Chiarini, V., Genovese, I., Ilari, A., & Colotti, G. (Apr. 2020). Roles of sorcin in Drug Resistance in Cancer: One protein, many mechanisms, for a novel potential Anticancer Drug Target. Cancers (Basel), 12(4), 887. https://doi.org/10.3390/cancers12040887 .
Mantovani, A., Allavena, P., Marchesi, F., & Garlanda, C. (2022). Macrophages as tools and targets in cancer therapy, Nat. Rev. Drug Discov, vol. 21, no. 11, pp. 799–820, Nov. https://doi.org/10.1038/s41573-022-00520-5 .
Chen, X., et al. (Jun. 2022). Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling. Cell Commun Signal, 20(1), 92. https://doi.org/10.1186/s12964-022-00888-2 .
Wu, Z., Bai, X., Lu, Z., Liu, S., & Jiang, H. (2022). LINC01094/SPI1/CCL7 Axis Promotes Macrophage Accumulation in Lung Adenocarcinoma and Tumor Cell Dissemination, J. Immunol. Res, vol. p. 6450721, Sep. 2022, https://doi.org/10.1155/2022/6450721 .
Zehtabi, M., et al. (2021). Estimation of Autophagy Activity by evaluating possible MicroRNA biomarkers and FOXO1 mRNA level in papillary thyroid carcinoma. Research Square Platform LLC. https://doi.org/10.21203/rs.3.rs-802917/v1 .
doi: 10.21203/rs.3.rs-802917/v1
Hou, X., et al. (Apr. 2021). LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma. Cell Death and Disease, 12(4), 347. https://doi.org/10.1038/s41419-021-03641-8 .
Bao, Y., et al. (Apr. 2020). Autophagy inhibition potentiates the anti-EMT effects of alteronol through TGF-β/Smad3 signaling in melanoma cells. Cell Death and Disease, 11(4), 223. https://doi.org/10.1038/s41419-020-2419-y .
Pan, G., Liu, Y., Shang, L., Zhou, F., & Yang, S. (2021). EMT-associated microRNAs and their roles in cancer stemness and drug resistance, Cancer Commun. (London, England), vol. 41, no. 3, pp. 199–217, Mar. https://doi.org/10.1002/cac2.12138 .
Islam Khan, M. Z., & Law, H. K. W. (Jun. 2021). RAMS11 promotes CRC through mTOR-dependent inhibition of autophagy, suppression of apoptosis, and promotion of epithelial-mesenchymal transition. Cancer Cell International, 21(1), 321. https://doi.org/10.1186/s12935-021-02023-6 .
Si, L., Yang, Z., Ding, L., & Zhang, D. (2022). Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: A new era for cancer treatment. Journal of Cancer Research and Clinical Oncology, 148(3), 547–564. https://doi.org/10.1007/s00432-021-03892-0 .
doi: 10.1007/s00432-021-03892-0
pubmed: 35083552
Li, W., Yan, P., Meng, X., Zhang, J., & Yang, Y. (2021). The microRNA cluster miR-214/miR-3120 prevents tumor cell switching from an epithelial to a mesenchymal-like phenotype and inhibits autophagy in gallbladder cancer. Cellular Signalling, 80, 109887. https://doi.org/10.1016/j.cellsig.2020.109887 .
doi: 10.1016/j.cellsig.2020.109887
pubmed: 33340658
Li, Y. (2022). Jun., CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt/β-catenin signalling pathway, Br. J. Cancer, vol. 126, no. 12, pp. 1684–1694, https://doi.org/10.1038/s41416-022-01747-0 .
Nalluri, S. M., et al. (2022). Crosstalk between ERK and MRTF-A signaling regulates TGFβ1‐induced epithelial‐mesenchymal transition. Journal of Cellular Physiology, 237(5), 2503–2515. https://doi.org/10.1002/jcp.30705 .
doi: 10.1002/jcp.30705
pubmed: 35224740
Saman, H., Raza, S. S., Uddin, S., & Rasul, K. (May 2020). Inducing angiogenesis, a key step in Cancer Vascularization, and treatment approaches. Cancers (Basel), 12(5), 1172. https://doi.org/10.3390/cancers12051172 .
Kuczynski, E. A., Vermeulen, P. B., Pezzella, F., Kerbel, R. S., & Reynolds, A. R. (2019). Vessel co-option in cancer. Nature Reviews. Clinical Oncology, 16(8), 469–493. https://doi.org/10.1038/s41571-019-0181-9 .
doi: 10.1038/s41571-019-0181-9
pubmed: 30816337
Finn, R. S., et al. (2020). Pembrolizumab as Second-Line therapy in patients with Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, phase III trial. Journal of Clinical Oncology, 38(3), 193–202. https://doi.org/10.1200/jco.19.01307 .
doi: 10.1200/jco.19.01307
pubmed: 31790344
Treps, L., Faure, S., & Clere, N. (2021). Vasculogenic mimicry, a complex and devious process favoring tumorigenesis – interest in making it a therapeutic target. Pharmacol & Ther, 223, 107805. https://doi.org/10.1016/j.pharmthera.2021.107805 .
doi: 10.1016/j.pharmthera.2021.107805
Angara, K. (2017). Abstract 787: Vascular mimicry mediated mechanisms drive therapy resistance in glioblastoma, Cancer Res, vol. 77, no. 13_Supplement, p. 787, https://doi.org/10.1158/1538-7445.am2017-787 .
Maiti, A., Qi, Q., Peng, X., Yan, L., Takabe, K., & Hait, N. C. (2019). Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells, Int. J. Oncol, vol. 55, no. 1, pp. 116–130, Jul. https://doi.org/10.3892/ijo.2019.4796 .
Jun, J., et al. (2021). Golph3 promotes vascular mimicry via the epithelial mesenchymal transition in glioblastoma cells. Turk Neurosurg. https://doi.org/10.5137/1019-5149.jtn.34807-21.2 .
doi: 10.5137/1019-5149.jtn.34807-21.2
Li, F., Xu, J., & Liu, S. (Apr. 2021). Cancer Stem cells and neovascularization. Cells, 10(5), 1070. https://doi.org/10.3390/cells10051070 .
Irani, S., & Dehghan, A. (2018). The expression and functional significance of vascular Endothelial-Cadherin, CD44, and Vimentin in oral squamous cell carcinoma. J Int Soc Prev Community Dent, 8(2), 110–117. https://doi.org/10.4103/jispcd.JISPCD_408_17 .
doi: 10.4103/jispcd.JISPCD_408_17
pubmed: 29780735
pmcid: 5946518
Cheng, T. (2022). EBV promotes vascular mimicry of dormant cancer cells by potentiating stemness and EMT, Exp. Cell Res, vol. 421, no. 2, p. 113403, https://doi.org/10.1016/j.yexcr.2022.113403 .
He, M., et al. (2022). Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling. Cancer Letters, 524, 15–28. https://doi.org/10.1016/j.canlet.2021.08.028 .
doi: 10.1016/j.canlet.2021.08.028
pubmed: 34461182
Izawa, Y. (2018). Dec., Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel, Acta Histochem. Cytochem, vol. 51, no. 6, pp. 173–183, https://doi.org/10.1267/ahc.18041 .
Gielata, M., Karpińska, K., Gwiazdowska, A., Boryń, Ł., & Kobielak, A. (2022). Catulin reporter marks a heterogeneous population of invasive breast cancer cells with some demonstrating plasticity and participating in vascular mimicry, Sci. Rep, vol. 12, no. 1, p. 12673, Jul. https://doi.org/10.1038/s41598-022-16802-2 .
Zhu, Z. (2020). Jul., Effect of gastric cancer stem cell on gastric cancer invasion, migration and angiogenesis, Int. J. Med. Sci, vol. 17, no. 13, pp. 2040–2051, https://doi.org/10.7150/ijms.46774 .
Chen, J., Chen, S., Zhuo, L., Zhu, Y., & Zheng, H. (2020). Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer, Cell Death Dis, vol. 11, no. 3, p. 173, Mar. https://doi.org/10.1038/s41419-020-2361-z .
Yang, C., Shi, S., Su, Y., Tong, J. S., & Li, L. (2020). P2X7R promotes angiogenesis and tumour-associated macrophage recruitment by regulating the NF-κB signalling pathway in colorectal cancer cells, J. Cell. Mol. Med, vol. 24, no. 18, pp. 10830–10841, Sep. https://doi.org/10.1111/jcmm.15708 .